Bora Pharmaceuticals Co., LTD. (TPE:6472)

Market Cap	74.15B
Revenue (ttm)	19.25B
Net Income (ttm)	3.94B
Shares Out	102.84M
EPS (ttm)	35.82
PE Ratio	20.13
Forward PE	14.02
Dividend	14.00 (1.87%)
Ex-Dividend Date	Aug 12, 2024

Volume	1,680,267
Average Volume	1,301,383
Open	746.00
Previous Close	750.00
Day's Range	720.00 - 747.00
52-Week Range	648.00 - 975.00
Beta	0.79
RSI	26.58
Earnings Date	Mar 7, 2025

About TPE:6472

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2024, TPE:6472's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.